G-01, GM IT Park, Plot No 32-33 Sector 142, Noida, Gautam Budh Nagar, Uttar Pradesh 201305, India info@rakshlife.com


DAPAGLIFLOZIN

Dapagliflozin is used to lower blood sugar in people with type 2 diabetes (condition in which blood sugar is too high because the body does not make or use insulin normally). To reduce the risk of being hospitalized for heart failure in certain adults with type 2 diabetes To reduce the risk of being hospitalized for heart failure and death in adults with heart failure To reduce the risk of worsening of kidney disease, being hospitalized for heart failure, and death in certain adults with kidney disease Dapagliflozin is in a class of medications called sodium-glucose co-transporter 2 (SGLT2) inhibitors. It lowers blood sugar by causing the kidneys to get rid of more glucose in the urine. Dapagliflozin is not used to treat type 1 diabetes (condition in which the body does not produce insulin and, therefore, cannot control the amount of sugar in the blood) or diabetic ketoacidosis (a serious condition that may develop if high blood sugar is not treated). Over time, people who have diabetes and high blood sugar can develop serious or life-threatening complications, including heart disease, stroke, kidney problems, nerve damage, and eye problems. Taking dapagliflozin, making lifestyle changes (e.g., diet, exercise, quitting smoking), and regularly checking your blood sugar may help to manage your diabetes and improve your health. This therapy may also decrease your chances of having a heart attack, stroke, or other diabetes-related complications such as kidney failure, nerve damage (numb, cold legs or feet; decreased sexual ability in men and women), eye problems, including changes or loss of vision, or gum disease. Your doctor and other healthcare providers will talk to you about the best way to manage your diabetes.

PACK: BLISTER    MRP:




DAPAGLIFLOZIN + METFORMIN

Dapagliflozin and metformin combination is used together with proper diet and exercise to treat type 2 diabetes. It is also used to lower the risk of hospitalization for heart failure in patients with type 2 diabetes and cardiovascular (heart or blood vessel) disease or multiple cardiovascular risk factors. This medicine is also used to lower the risk of cardiovascular death, hospitalization, and urgent heart failure visit in patients with heart failure with reduced ejection fraction (the heart is weak and cannot pump enough blood to the rest of the body). Dapagliflozin and metformin combination is also used to lower the risk of worsening of kidney disease, end stage kidney disease, cardiovascular death, and hospitalization for heart failure in patients with chronic kidney disease. Dapagliflozin works in the kidneys to prevent absorption of glucose (blood sugar). This helps lower the blood sugar level. Metformin reduces the absorption of sugar from the stomach, reduces the release of stored sugar from the liver, and helps your body use sugar better. It does not help patients who have insulin-dependent or type 1 diabetes. Type 1 diabetic patients must use insulin injections. This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Tablet, Extended Release

PACK: BLISTER    MRP:




DAPAGLIFLOZIN + METFORMIN

Dapagliflozin and metformin combination is used together with proper diet and exercise to treat type 2 diabetes. It is also used to lower the risk of hospitalization for heart failure in patients with type 2 diabetes and cardiovascular (heart or blood vessel) disease or multiple cardiovascular risk factors. This medicine is also used to lower the risk of cardiovascular death, hospitalization, and urgent heart failure visit in patients with heart failure with reduced ejection fraction (the heart is weak and cannot pump enough blood to the rest of the body). Dapagliflozin and metformin combination is also used to lower the risk of worsening of kidney disease, end stage kidney disease, cardiovascular death, and hospitalization for heart failure in patients with chronic kidney disease. Dapagliflozin works in the kidneys to prevent absorption of glucose (blood sugar). This helps lower the blood sugar level. Metformin reduces the absorption of sugar from the stomach, reduces the release of stored sugar from the liver, and helps your body use sugar better. It does not help patients who have insulin-dependent or type 1 diabetes. Type 1 diabetic patients must use insulin injections. This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Tablet, Extended Release

PACK: BLISTER    MRP:


Our Manufacturing Facility For Oral Solid Dosage (Tabs, Caps, Sachet) Plot No.8, Sector-6A, I.I.E., SIDCUL, Haridwar, India For Pre-filled Syringes Plot No. 450, Opposite Nirma Factory, Chhatral, Tal Kalol District Gandhinagar, Gaujarat, India

Contacts

G-01, GM IT Park, Plot No 32-33 Sector 142, Noida, Gautam Budh Nagar, Uttar Pradesh 201305, India
911204288400
911204288400

Other Location

Plot No.8, Sector-6A, I.I.E., SIDCUL, Haridwar, India
Plot No. 450, Opposite Nirma Factory, Chhatral, Tal Kalol District Gandhinagar, Gaujarat, India